← Back to All Filings

Guardant Health CTO Darya Chudova Sells $1.38M in Common Stock

Medium SignificanceSeptember 17, 2026 at 6:57:58 PM EDT

Guardant Health, Inc.

$GH4CIK: 0001576280

Subscribe to track GH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📊 Insider Sale Alert: Guardant Health, Inc. ($GH) Insider: Darya Chudova (Chief Technology Officer) Transaction: Sold 7,738 shares of Common Stock at $178.00 per share Total Value: $1,377,364.00 Shares Remaining: 70,635 Filing Date: 2026-09-17

Comprehensive Analysis

Executive Summary

On September 15, 2026, Darya Chudova, Chief Technology Officer of Guardant Health, Inc. ($GH), executed an open-market sale of 7,738 shares of common stock at a price of $178.00 per share, yielding gross proceeds of approximately $1.38 million. Following the disposition, Chudova continues to hold 70,635 shares directly.

Transaction Details

  • Security: Common Stock
  • Transaction Code: S (Open market or private sale)
  • Shares Sold: 7,738
  • Execution Price: $178.00
  • Total Transaction Value: $1,377,364.00
  • Post-Transaction Direct Ownership: 70,635 shares
  • 10b5-1 Plan Adoption: No indication of Rule 10b5-1 plan usage (aff10b5One is marked 0).

Market Impact & Significance

The sale represents roughly 9.87% of the insider's direct holding prior to the transaction. Given the transaction value exceeding $1 million and the absence of an indicated Rule 10b5-1 trading plan, the filing warrants a Medium significance rating, though the executive retains a substantial equity interest in the company.

Topics:#GuardantHealth#GH#InsiderTrading#Form4#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.